TY  - JOUR
AU  - De Laurentiis, Michelino
AU  - Borstnar, Simona
AU  - Campone, Mario
AU  - Warner, Ellen
AU  - Bofill, Javier Salvador
AU  - Jacot, William
AU  - Dent, Susan
AU  - Martin, Miguel
AU  - Ring, Alistair
AU  - Cottu, Paul
AU  - Lu, Janice
AU  - Ciruelos, Eva
AU  - Azim, Hamdy A
AU  - Chatterjee, Sanjoy
AU  - Zhou, Katie
AU  - Wu, Jiwen
AU  - Menon-Singh, Lakshmi
AU  - Zamagni, Claudio
PY  - 2022
DO  - 10.1007/s10549-021-06374-6
UR  - https://hdl.handle.net/10668/27207
T2  - Breast cancer research and treatment
LA  - en
TI  - Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
TY  - research article
VL  - 191
ER  -